Literature DB >> 14618556

A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease.

D J Hart1, D Craig, S A Compton, S Critchlow, B M Kerrigan, S P McIlroy, A P Passmore.   

Abstract

AIM: To document the behavioural and psychological symptoms in patients with a diagnosis of established Alzheimer's disease (AD) for at least 3 years.
METHODS: Patients with a > or =3 year history of AD (NINCDS/ADRDA) were recruited from old age psychiatrist and elderly care memory clinics. Information regarding duration of symptoms and non-cognitive symptomatology was obtained during interview with a carer or next-of-kin who had contact with the patient at least 3 times a week and for at least 3 years. MMSE, FAST and NPI including caregiver distress, were used to assess cognition, function and behavioural/psychological disturbance respectively. With each non-cognitive symptom the carer was asked to estimate its onset.
RESULTS: The mean age of patients was 77 years and duration of illness 87 months. Mean MMSE was 8/30 and FAST score 6d. Of the psychological symptoms occurring at any stage, depression (56%), delusions (55%) and anxiety (52%) were most common, with hallucinations, elation and disinhibition occurring less frequently. In general, behavioural changes were more common with apathy occurring in 88% of patients, motor behaviour in 70%, aggression in 66%, irritability and appetite changes in 60% and sleep disturbance in 54%. All symptoms except apathy became less common when the carer was asked if they were still present in the last month. Mean onset of psychological symptoms was 47 months. Mean onset of behavioural symptoms was 48 months. Behavioural disturbance seemed to cause more care-giver distress than psychological change.
CONCLUSION: The results show behavioural and psychological symptoms in AD are common and distressing for carers. They appear to require a consistent period of neurodegeneration in order to emerge. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 14618556     DOI: 10.1002/gps.1013

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  30 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  The involvement of multiple caregivers in cognitive-behavior therapy for anxiety in persons with dementia.

Authors:  Christina M Robinson; Amber Paukert; Cynthia A Kraus-Schuman; A Lynn Snow; Mark E Kunik; Nancy L Wilson; Linda Teri; Melinda A Stanley
Journal:  Aging Ment Health       Date:  2011-04       Impact factor: 3.658

3.  Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease.

Authors:  Carolyn W Zhu; Elayne E Livote; Kristin Kahle-Wrobleski; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Apr-Jun       Impact factor: 2.703

4.  TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism.

Authors:  Youngsin Jung; Dennis W Dickson; Melissa E Murray; Jennifer L Whitwell; David S Knopman; Bradley F Boeve; Clifford R Jack; Joseph E Parisi; Ronald C Petersen; Keith A Josephs
Journal:  J Neurol       Date:  2014-04-24       Impact factor: 4.849

Review 5.  Pharmacotherapies for sleep disturbances in dementia.

Authors:  Jenny McCleery; Daniel A Cohen; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2016-11-16

Review 6.  Connected speech and language in mild cognitive impairment and Alzheimer's disease: A review of picture description tasks.

Authors:  Kimberly D Mueller; Bruce Hermann; Jonilda Mecollari; Lyn S Turkstra
Journal:  J Clin Exp Neuropsychol       Date:  2018-04-19       Impact factor: 2.475

Review 7.  Effects of cholinesterase inhibitors on behavioural disturbances in Alzheimer's disease: a systematic review.

Authors:  Timo Grimmer; Alexander Kurz
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

8.  Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease.

Authors:  Yosef A Berlow; William M Wells; James M Ellison; Young Hoon Sung; Perry F Renshaw; David G Harper
Journal:  Int J Geriatr Psychiatry       Date:  2010-08       Impact factor: 3.485

9.  Cognitive-behavioral treatment for anxiety in patients with dementia: two case studies.

Authors:  Cynthia A Kraus; Paul Seignourel; Valli Balasubramanyam; A Lynn Snow; Nancy L Wilson; Mark E Kunik; Paul E Schulz; Melinda A Stanley
Journal:  J Psychiatr Pract       Date:  2008-05       Impact factor: 1.325

Review 10.  Neurologic and motor dysfunctions in APP transgenic mice.

Authors:  Robert Lalonde; Ken-Ichiro Fukuchi; Catherine Strazielle
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.